KINETA, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.472 USD | -3.08% |
|
-15.43% | -87.00% |
| 04-08 | Kineta, Inc. Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 Vista-101 Clinical Trial | CI |
| 03-21 | Earnings Flash (KA) KINETA Posts 2023 Revenue $5.4M | MT |
- Stock Market
- Equities
- KA Stock
- News Kineta, Inc.
- MarketScreener Strategies
